Cargando…
Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors
Recurrent neoepitopes are cancer-specific antigens common among groups of patients and therefore ideal targets for adoptive T cell therapy. The neoepitope FSGEYIPTV carries the Rac1P29S amino acid change caused by a c.85C>T missense mutation, which is the third most common hotspot mutation in mel...
Autores principales: | Immisch, Lena, Papafotiou, George, Gallarín Delgado, Nerea, Scheuplein, Vivian, Paschen, Annette, Blankenstein, Thomas, Willimsky, Gerald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978334/ https://www.ncbi.nlm.nih.gov/pubmed/36875127 http://dx.doi.org/10.3389/fimmu.2023.1119498 |
Ejemplares similares
-
In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo
por: Willimsky, Gerald, et al.
Publicado: (2021) -
H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma
por: Immisch, Lena, et al.
Publicado: (2022) -
Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al
por: Immisch, Lena, et al.
Publicado: (2023) -
The neoepitope landscape in pediatric cancers
por: Chang, Ti-Cheng, et al.
Publicado: (2017) -
Pan-cancer analysis of neoepitopes
por: Teku, Gabriel N., et al.
Publicado: (2018)